Rigense logo
Back to all news
Technology

Panic grips Ionis Pharmaceuticals investors amid bad news spree

finance.yahoo.com·12 hours ago·Global·1 min read
Source: finance.yahoo.com

A single failed trial can undo years of work in one trading session, and Ionis Pharmaceuticals (IONS) just went through both consecutively.

Ionis Pharmaceuticals lost nearly a quarter of its value on July 9 after its heart drug Wainua failed to meet the primary goal of a late-stage trial.

The...

ONLY AVAILABLE IN PAID PLANS

Read original source

Related news